ACE2 and glycogen storage disease VI: Understanding the physical mechanism responsible for the outstanding affinity between the SARS‐CoV‐2 S and ACE2 is an “urgent challenge” for developing blockers, vaccines, and therapeutic antibodies against the coronavirus disease 2019 (COVID‐19) pandemic.